Folate-modified liposomes for co-delivery of schisandrin A and oxaliplatin to enhance colorectal cancer cell death

Abstract The incidence of colorectal cancer (CRC) poses a significant threat to human life. Immunotherapy has emerged as an efficacious treatment against CRC. However, it is hindered by the challenge of inadequate immunogenicity. In addition to exerting inhibitory effects on cancer cell activity, th...

Full description

Bibliographic Details

Published in:	Discover Oncology
Main Authors:	Bo Zhou, WanRu Dong, Yuhan Fu, Qianqian Jiang
Format:	Article
Language:	English
Published:	Springer 2025-08-01
Subjects:	Liposomes Oxaliplatin Immunogenic cell death Colorectal cancer Active targeting Schisandrin A
Online Access:	https://doi.org/10.1007/s12672-025-03164-0